Company Filing History:
10 out of 18 
4 out of 541 
1 out of 1 Years Active: 2011-2025
Title: Karin Von Wachenfeldt: Innovator in Antibody Research
Introduction
Karin Von Wachenfeldt is an accomplished inventor based in Lund, Sweden. With a remarkable portfolio of 14 patents, she has made significant contributions to the field of biomedicine, particularly in the development of therapeutic antibodies. Her innovative work continues to influence medical research and treatment methodologies.
Latest Patents
Among her recent innovations, one of her notable patents involves an Anti-IL1RAP antibody. This invention pertains to an antibody or an antigen-binding fragment with specificity for the interleukin-1 receptor accessory protein (IL1RAP). The patent also encompasses a polynucleotide encoding the antibody, along with a vector and recombinant host cell featuring said polynucleotide. Furthermore, it outlines a method for producing the antibody, emphasizing its potential use in medical treatments for diseases associated with IL-1α, IL-1β, IL-33, IL-36α, IL-36β, and IL-36γ signaling pathways.
Another significant patent from Karin is a pharmaceutical composition that represents a combination of methotrexate and novobiocin, along with their pharmaceutically acceptable salts. This innovation aims to enhance therapeutic effectiveness in treating autoimmune diseases, indicating her commitment to addressing pressing medical challenges through her inventive work.
Career Highlights
Karin has garnered experience and expertise working with prominent organizations such as Cantargia AB and MedImmune Limited. Her impressive career highlights reflect her dedication to advancing research and development in the pharmaceutical industry, particularly in antibody therapy and autoimmune disease treatment.
Collaborations
Throughout her career, Karin has collaborated with esteemed colleagues, including Kjell Sjöström and Helena Ågerstam. These partnerships have provided valuable insights and shared knowledge, further amplifying the impact of her inventions within the scientific community.
Conclusion
Karin Von Wachenfeldt exemplifies the spirit of innovation through her groundbreaking patents and contributions to biomedicine. Her work not only aids in understanding complex diseases but also offers new therapeutic avenues for treatment, showcasing her invaluable role as an inventor in the modern medical landscape.